Published on Jun 22, 2016 - Shan Lu, MD, PhD, professor of medicine at the University of Massachusetts Medical School, has received $17.3 million from the National Institute of Allergy and Infectious Diseases (NIAID) to develop and produce an optimized HIV vaccine to be used in Phase II human clinical trials. The seven-year program builds on two decades of scientific progress by Dr. Lu, a leader in HIV vaccine research, and marks a major milestone in the field of HIV vaccine development.
